Inconsistent with the results of previous studies, our findings suggest that PD leads to reduced levels of inflammatory factors such as MIG, bNGF, IL-17, IL-2, and IFNg through pathological pathways, which may be attributed to the fact that the levels of inflammatory markers are influenced by the course, extent, and duration of PD. Here, IL17A is linked to Parkinson disease.